For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Cg Oncology Inc (NASDAQ: CGON) closed at $28.76 down -0.38% from its previous closing price of $28.87. In other words, the price has decreased by -$0.38 from its previous closing price. On the day, 3.27 million shares were traded. CGON stock price reached its highest trading level at $29.95 during the session, while it also had its lowest trading level at $27.58.
Ratios:
For a deeper understanding of Cg Oncology Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 35.32 and its Current Ratio is at 35.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $60.
On September 23, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $66.
On August 28, 2024, ROTH MKM started tracking the stock assigning a Buy rating and target price of $65.ROTH MKM initiated its Buy rating on August 28, 2024, with a $65 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 06 ’24 when POST LEONARD E sold 1,000 shares for $34.54 per share. The transaction valued at 34,542 led to the insider holds 0 shares of the business.
LEONARD E POST bought 4,000 shares of CGON for $134,240 on Dec 06 ’24. On Aug 29 ’24, another insider, Song Hong Fang, who serves as the Director of the company, sold 650,455 shares for $35.36 each. As a result, the insider received 23,000,089 and left with 586,982 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 1945030016 and an Enterprise Value of 1404615424. For the stock, the TTM Price-to-Sale (P/S) ratio is 2849.44 while its Price-to-Book (P/B) ratio in mrq is 3.62. Its current Enterprise Value per Revenue stands at 2053.531 whereas that against EBITDA is -14.641.
Stock Price History:
Over the past 52 weeks, CGON has reached a high of $50.23, while it has fallen to a 52-week low of $25.77. The 50-Day Moving Average of the stock is -18.48%, while the 200-Day Moving Average is calculated to be -18.97%.
Shares Statistics:
For the past three months, CGON has traded an average of 665.35K shares per day and 967340 over the past ten days. A total of 67.54M shares are outstanding, with a floating share count of 41.40M. Insiders hold about 38.78% of the company’s shares, while institutions hold 61.80% stake in the company. Shares short for CGON as of 1732838400 were 5267202 with a Short Ratio of 7.92, compared to 1730332800 on 5598991. Therefore, it implies a Short% of Shares Outstanding of 5267202 and a Short% of Float of 7.8600004000000006.
